Retatrutide

Retatrutide is a synthetic peptide characterized in the published preclinical literature as a triple agonist at the GLP-1, GIP, and glucagon receptors. It is used as a research reagent in in-vitro receptor-binding, cAMP-signaling, and preclinical metabolic-pathway assays that investigate incretin- and glucagon-receptor pharmacology in cultured cell and rodent model systems. Commonly used in academic metabolic-signaling research. Supplied as a lyophilized powder for laboratory use. For research and analytical purposes only. Not for human or veterinary consumption. No therapeutic, diagnostic, or clinical claims are made or implied. Content pending internal legal review.

Batch documentation available when applicable.